Clinical Trials | May 02, 2023
Lilly's Lebrikizumab shows improved face or hand dermatitis
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
The business serves the healthcare and laboratory sectors on the west coast of the United States.
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
With more than 35 years of experience, Best Formulations is the largest manufacturer of plant-based softgels in the United States, with newly expanded capabilities for nutritional gummies and personal care
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
Fund VI will focus on investments in industrials and healthcare businesses with proven technologies and solutions positioned to deliver high performance and value-add to their customers
The combined company will be able to better serve both our global and regional customers with local production
Subscribe To Our Newsletter & Stay Updated
